Leonteq Securities’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.2K Buy
434
+403
+1,300% +$23.6K ﹤0.01% 825
2026
Q2
$1.19K Sell
31
-41
-57% -$1.07K ﹤0.01% 1173
2026
Q1
$1.53K Buy
72
+63
+700% +$1.26K ﹤0.01% 1181
2025
Q4
$147 Hold
9
– – ﹤0.01% 1406
2025
Q3
$105 Sell
9
-149,043
-100% -$1.94M ﹤0.01% 1301
2025
Q2
$1.73M Buy
149,052
+36,995
+33% +$337K 0.07% 176
2025
Q1
$982K Buy
112,057
+25,894
+30% +$326K 0.06% 262
2024
Q4
$1.24M Buy
86,163
+51,088
+146% +$806K 0.08% 209
2024
Q3
$792K Buy
35,075
+15,534
+79% +$321K 0.06% 249
2024
Q2
$380K Buy
19,541
+13,859
+244% +$363K 0.03% 361
2024
Q1
$213K Buy
5,682
+4,837
+572% +$213K 0.02% 490
2023
Q4
$47.3K Sell
845
-3,585
-81% -$156K ﹤0.01% 803
2023
Q3
$183K Buy
4,430
+3,507
+380% +$182K 0.01% 546
2023
Q2
$51.5K Buy
+923
New +$50K ﹤0.01% 822
2023
Q1
– Sell
-2,500
Closed -$91.1K – 1334
2022
Q4
$91.1K Sell
2,500
-459
-16% -$15K ﹤0.01% 687
2022
Q3
$84.3K Buy
2,959
+175
+6% +$6.67K ﹤0.01% 678
2022
Q2
$126K Buy
2,784
+2,503
+891% +$130K ﹤0.01% 639
2022
Q1
$21.4K Buy
281
+258
+1,122% +$22.6K ﹤0.01% 1000
2021
Q4
$3.43K Buy
+23
New +$3.52K ﹤0.01% 1204
2021
Q2
– Sell
-184
Closed -$33.3K – 1132
2021
Q1
$33.3K Buy
+184
New +$31.8K ﹤0.01% 826

Other funds holding TXG

Leonteq Securities's TXG Position: Q3 2026 in Review

Leonteq Securities increased its 10x Genomics (TXG) stake by 1,300% in Q3 2026, buying an estimated $23.6K and bringing the position to 434 shares worth $39.2K. The position accounts for ﹤0.01% of the portfolio, ranked #825.

Leonteq Securities first reported a position in TXG in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.73M in Q2 2025. 389 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Leonteq Securities held 434 shares of 10x Genomics worth $39.2K as of Q3 2026.
  • Leonteq Securities bought 403 10x Genomics shares in Q3 2026, an estimated $23.6K.
  • 10x Genomics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #825 holding.
  • Leonteq Securities first reported a position in 10x Genomics in Q1 2021 and has held it in 20 quarters since.
  • Leonteq Securities's 10x Genomics position peaked at $1.73M in Q2 2025.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.